OXIGENE, INC.

Company

Oncotelic Therapeutics, Inc.

Filed

March 30, 2009

Period of Report

December 31, 2008

Accession Number

0000950135-09-002248

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →